Matthew Quan, MD
MOHS-Micrographic Surgery · New York, NYNPI 1578535910
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 57 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $424 and has fallen 59.2% since, to $173 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in NY, where the typical reported total is $1,291.
Across 57 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$159
- Pfizer$143
- LEO Pharma Inc.$129
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$106
- Johnson & Johnson$76
- Galderma Laboratories, L.p.$73
- plus $442 from 13 others
What the payments were for
- Food & beverage$1,127100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 2 | $159 |
| Pfizer | 9 | $143 |
| LEO Pharma Inc. | 7 | $129 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $106 |
| Johnson & Johnson | 4 | $76 |
| Galderma Laboratories, L.p. | 5 | $73 |
| Novartis | 4 | $65 |
| Lilly USA, LLC | 4 | $63 |
| AbbVie(2 entities) | 3 | $55 |
| Journey Medical Corporation | 3 | $45 |
| Merz North America, Inc. | 1 | $44 |
| Biofrontera Inc. | 2 | $41 |
| Dermira, Inc. | 1 | $25 |
| Genentech USA, Inc. | 1 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $21 |
| Mayne Pharma Commercial LLC | 1 | $18 |
| Sanofi | 1 | $17 |
| Boston Scientific | 1 | $12 |
| EPI Health, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$129
How this compares
$1,127 in reported general payments places this provider in the 45th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other mohs-micrographic surgery in New York
- Ellen MarmurNew York$186K
- Michael TassavorNew York$55K
- Jane YooNew York$42K
- Hamza BhattiNew York$40K
- Desiree RatnerNew York$32K
- Omar Torres LozadaNew York$13K
- Ronald SheltonNew York$10K
- Sarah YagermanNew York$8K
- John CarucciNew York$6K
- Faramarz SamieNew York$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.